𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C

✍ Scribed by Nicolas Flori, Natalie Funakoshi, Yohan Duny, Jean-Christophe Valats…


Book ID
120804711
Publisher
Springer International Publishing AG
Year
2013
Tongue
English
Weight
577 KB
Volume
73
Category
Article
ISSN
0012-6667

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Merimepodib, pegylated interferon, and r
✍ Vinod K. Rustgi; William M. Lee; Eric Lawitz; Stuart C. Gordon; Nezam Afdhal; Fr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

on behalf of the MErimepodib TRiple cOmbination (METRO) study group Merimepodib (MMPD) is an orally administered, inosine monophosphate dehydrogenase inhibitor that has shown antiviral activity in nonresponders with chronic hepatitis C (CHC) when combined with pegylated interferon alfa 2a (Peg-IFN-a